Gansu Province, in vitro diagnostic reagents officially hanged

Medical Network November 1st, October 30th, Gansu issued the "In vitro Diagnostic Reagents Sunshine Purchasing Implementation Plan" (hereinafter referred to as the draft of the opinion), clearly stipulates that the reagents should be purchased from the net, and share the data of the reagents of the Chongqing Drug Exchange and Based on the experience of high-value hanging nets, three network catalogues are formed, and peer reporting is encouraged, and price segment management is implemented.

As early as August 7 this year, Gansu and Chongqing signed the "Regional Cooperation Agreement on Pharmaceutical Trade", clarifying the mutual recognition of qualification audit results between the two places, regional procurement data sharing mechanism, cross-regional joint procurement, cross-regional product prices. Linkage, shortage drug Information sharing, cross-regional procurement platform information collaboration, regional alliance expert think tank construction, regional exchange activities and other aspects of cooperation, marking the two countries in the pharmaceutical field officially 'marriage'.

With the launch of the Gansu reagent project, the inter-provincial cooperation wind has gradually spread to the consumables sector. At the same time, the blessing of the membership of the Gansu Provincial Union has also made the outside world look forward to cross-regional cooperation between the two places!

Reagent nets draw on high-value procurement experience, encourage peers to report reference prices

The reagents of Gansu draw on the formation principle of the high-value net catalogue in 2016. It is also divided into three categories: procurement, alternative and filing. The specific catalog formation mechanism and the respective reference price sources of the nets are as shown in the following figure:

Gansu encourages peers to report and publicize the reference price of the net. Once enterprise Violation of the principle of good faith will be given a corresponding breach of contract. And for companies that have clarified and re-publicized, if there are more than 5 products in the same category, the problem of false reporting, cancel the network of all products of this enterprise. Qualification, and give a bad record 1 time.

At the same time, the price and catalogue are dynamically adjusted. The price in the procurement catalogue is adjusted according to the actual purchase price in the province or the price of the Chongqing Stock Exchange. The products in the alternative catalogue are adjusted according to the new low bid/net price in other provinces in the country. If the enterprise has overdue non-declaration, it will be suspended.

In addition, the provincial platform will have no hospital purchase The recorded products are downgraded and transferred to the alternative catalogue. Products that are not on the provincial platform, but in other provinces with the winning bid (net) record and price, will be included in the alternative catalogue purchase according to the enterprise application. .

Implementation of price segment management, the province's purchase price continues to decline

Gansu requires that the price agreed by the hospital should not be higher than the reference price of the net and the original purchase price. Encourage the hospital to negotiate with the enterprise according to the principle of “purchasing quantity, price-price linkage”. The hospital can also explore joint procurement to further reduce the purchase price. The internal purchase price is subject to segment management (providing the hospital with the purchase price chromatic aberration section prompt).

According to the price, the third grade is divided into high, medium and low. Each section is subdivided into upper and lower three sections. Each section displays different colors. The system automatically displays the current purchase price of the hospital. The hospital adjusts the purchase price according to the price section. The segment will change in real time as the hospital's purchase price changes. No doubt the province's purchase price will continue to fall.

Aftershocks after the longevity biological vaccine case, Gansu strictly controls the quality

After the Changchun Changsheng Biological Vaccine case in Jilin, it not only triggered medicine The supervision of the circle has been strengthened, and it has also spread to the medical circle. In September this year, a director of the State Food and Drug Administration said that the number of flying inspection enterprises was not enough this year. In the future, the number of flight inspections should be increased. The number has to be doubled. Locally Zhejiang, Inner Mongolia, and Putian also implemented a second ban on the procurement side, and canceled the qualification for the products that failed to pass the inspection. In this opinion draft, Gansu’s reagents for quality are also strengthened. The control details are as follows:

Summary: This year, the alliance continues to be hot, and the new trends of the provincial alliance are also particularly eye-catching. In the horizontal expansion, the members of the alliance also rely on 'foreign aid', and the former Liaoning has expressed its connection with the Beijing-Tianjin-Hebei Union. Gansu also shares the reagent procurement data of the Chongqing Drug Exchange. In this context, a cross-linked price linkage network is being woven across the country.